Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)
China · Delayed Price · Currency is CNY 111.58
+5.33 (5.02%)
Sep 30, 2026, 3:00 PM CST
SHA:688578 Market Cap
SHA:688578 has a market cap or net worth of 50.21 billion as of October 2, 2026. Its market cap has increased by 5.41% in one year.
Market Cap
50.21B
Enterprise Value
45.97B
Revenue
6.13B
Ranking
n/a
PE Ratio
18.79
Stock Price
111.58
ChartMarket Cap Chart
Since December 2, 2020, SHA:688578's market cap has increased from 17.35B to 50.21B, an increase of 189.44%. That is a compound annual growth rate of 20.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 50.21B | 7.13% |
| Dec 31, 2025 | 46.87B | 73.87% |
| Dec 31, 2024 | 26.96B | 43.78% |
| Dec 29, 2023 | 18.75B | 111.69% |
| Dec 30, 2022 | 8.86B | -34.83% |
| Dec 31, 2021 | 13.59B | 6.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmaron Beijing | 76.18B |
| Haisco Pharmaceutical Group | 68.97B |
| Asymchem Laboratories (Tianjin) | 66.64B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.13B |
| Shanghai RAAS Blood Products | 35.07B |
| Beijing Wantai Biological Pharmacy Enterprise | 34.57B |
| Chongqing Zhifei Biological Products | 33.47B |
| Suzhou Zelgen Biopharmaceuticals | 29.12B |